Cohen Veterans Bioscience, Stanford Brain Performance Center, and Brain Trauma Foundation Join Forces to Advance Precision Medicine for TBIAugust 9, 2021Read more
Cohen Veterans Bioscience, Stanford Brain Performance Center, and the Brain Trauma Foundation announced a collaboration aimed at transforming the treatment recommendations and guidelines for mild traumatic brain injury (TBI) (inclusive of concussion) and advancing the field more broadly toward a precision medicine approach.
- July 6, 2021Read more
The coauthored review discusses the state of preclinical research in traumatic brain injury (TBI), how preclinical models contribute to the success and failure of clinical solutions for TBI, and considerations for their improvement to aid translational science.
- June 28, 2021Read more
Chief Information Officer Dr. Lee Lancashire discusses how CVB’s approach to data modeling is helping to advance research for trauma-related brain disorders, such as PTSD and TBI.
- June 23, 2021Read more
The new PRISM 2 project, “Psychiatric Ratings using Intermediate Stratified Markers 2,” aims to identify quantitative biological features common across Alzheimer’s disease, schizophrenia and major depressive disorder, opening the possibility of developing targeted treatments irrespective of traditional diagnosis.